These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 9846248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G.
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [Abstract] [Full Text] [Related]

  • 3. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G, Giguère JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF.
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM, Jensen TU, Emborg J.
    Ugeskr Laeger; 2000 Aug 28; 162(35):4681-4. PubMed ID: 10986901
    [Abstract] [Full Text] [Related]

  • 8. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E, Kahraman H, Onar M, Kesim G, Arik Z.
    East Afr Med J; 1997 Apr 28; 74(4):210-2. PubMed ID: 9299818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2001 Apr 28; (4):CD002798. PubMed ID: 11687160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
    Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, de Sá MF.
    Hepatogastroenterology; 1992 Dec 28; 39(6):542-5. PubMed ID: 1483668
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study.
    Dursun M, Caliskan M, Canoruc F, Aluclu U, Canoruc N, Tuzcu A, Yilmaz S, Isikdogan A, Ertem M.
    Swiss Med Wkly; 2003 Feb 22; 133(7-8):118-23. PubMed ID: 12644958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.